By Tom Herd, Seth Van Winkle and Tim Ziemann – Accenture 2015 was a banner year for mergers and acquisitions with a record $4.7 trillion in
By PricewaterhouseCoopers Special Issue: Health Industries Updates in Australia Australia Exploring the benefits and costs of biomarkers In recent years there
Americas Region. Americas Financial Advisory. August 2016 By Deloitte Executive summary Majority of M&A deals in Latin America during 2016 have
by KPMG
The number of completed deals remained high in both sectors in HY1 2016. While total deal value for pharmaceuticals decreased, chemicals witnessed a 40% increase in HY1 2016 versus HY1 2015. Pharmaceutical M&A was impacted by stock market volatility, while new US regulatory rules struck down the $160 billion Pfizer-Allergan merger. Oncology and dermatology were key areas of interest for big pharma, who were especially keen on acquiring biotech assets. […] Read more
By Rita Duran, Helen Christmann, Daniel Pietzker– KPMG Contributors: Andy Qiu, Austin Wang HIGHLIGHTS — The number of completed deals remained high in both sectors
Available in our e-library on M&A at IMAA! Authors: Joseph Heagney Publisher: AMACOM Year: 2016 (August) ISBN: 9780814437377 Content Fundamentals of Project
Trainings
In order to become a charterholder you need to complete one of the IMAA programs
